In addition, our previous studies revealed that most ovarian cancer cell lines show functional resistance to the anti-EGFR antibody cetuximab which could not be resolved by the simultaneous addition of the corresponding anti-EGFR TKIs [24]. Here, EGFR is linked to ovarian carcinoma.